These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 35074332)

  • 41. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
    Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD
    Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.
    SeyedAlinaghi S; Mirzapour P; Dadras O; Pashaei Z; Karimi A; MohsseniPour M; Soleymanzadeh M; Barzegary A; Afsahi AM; Vahedi F; Shamsabadi A; Behnezhad F; Saeidi S; Mehraeen E; Shayesteh Jahanfar
    Eur J Med Res; 2021 Jun; 26(1):51. PubMed ID: 34103090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
    Mattiuzzi C; Henry BM; Lippi G
    Int J Infect Dis; 2022 May; 118():167-168. PubMed ID: 35278677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants.
    Jing S; Milne R; Wang H; Xue L
    J Theor Biol; 2023 Aug; 570():111522. PubMed ID: 37210068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.
    Ibarrondo FJ; Hofmann C; Ali A; Ayoub P; Kohn DB; Yang OO
    mBio; 2021 Dec; 12(6):e0265621. PubMed ID: 34872349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The variants question: What is the problem?
    Zella D; Giovanetti M; Benedetti F; Unali F; Spoto S; Guarino M; Angeletti S; Ciccozzi M
    J Med Virol; 2021 Dec; 93(12):6479-6485. PubMed ID: 34255352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
    Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
    Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A New Wave of COVID-19 in 2021 with Unique Genetic Characters - Present Global Scenario and Beholding Onwards.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(6):e010422202932. PubMed ID: 35366784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2.
    Dimeglio C; Milhes M; Loubes JM; Ranger N; Mansuy JM; Trémeaux P; Jeanne N; Latour J; Nicot F; Donnadieu C; Izopet J
    Viruses; 2021 May; 13(5):. PubMed ID: 34066231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The omicron variant of SARS-CoV-2: Understanding the known and living with unknowns.
    Ingraham NE; Ingbar DH
    Clin Transl Med; 2021 Dec; 11(12):e685. PubMed ID: 34911167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.
    Giordano G; Colaneri M; Di Filippo A; Blanchini F; Bolzern P; De Nicolao G; Sacchi P; Colaneri P; Bruno R
    Nat Med; 2021 Jun; 27(6):993-998. PubMed ID: 33864052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The global epidemic of SARS-CoV-2 variants and their mutational immune escape.
    Tian D; Sun Y; Zhou J; Ye Q
    J Med Virol; 2022 Mar; 94(3):847-857. PubMed ID: 34609003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elucidating reasons of COVID-19 re-infection and its management strategies.
    Jain VK; Iyengar K; Garg R; Vaishya R
    Diabetes Metab Syndr; 2021; 15(3):1001-1006. PubMed ID: 33989898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Worldwide vaccine inequality threatens to unleash the next COVID-19 variant.
    Oehler RL; Vega VR
    Int J Infect Dis; 2022 Oct; 123():133-135. PubMed ID: 35988865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current surge of COVID-19 infection in China and its impact on India.
    Gupta E; Samal J; Gautam P; Agarwal R
    Indian J Med Microbiol; 2023; 42():46-48. PubMed ID: 36967215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease.
    Zawbaa HM; Osama H; El-Gendy A; Saeed H; Harb HS; Madney YM; Abdelrahman M; Mohsen M; Ali AMA; Nicola M; Elgendy MO; Ibrahim IA; Abdelrahim MEA
    J Med Virol; 2022 Jan; 94(1):197-204. PubMed ID: 34427922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to translate the knowledge of COVID-19 into the prevention of Omicron variants.
    Wang X; Powell CA
    Clin Transl Med; 2021 Dec; 11(12):e680. PubMed ID: 34898050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolving trend change during the COVID-19 pandemic.
    Gao L; Zheng C; Shi Q; Xiao K; Wang L; Liu Z; Li Z; Dong X
    Front Public Health; 2022; 10():957265. PubMed ID: 36203708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.